Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
This volatility comparison pits the dividend aristocrats ETF against the SP500 to help you evaluate relative risk and inform allocation decisions.
20,401 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Amazon delivered strong AWS growth and solid Q1 results, but a large capex plan keeps investors wary. Still, a broad ...
Seagate Technology’s stock is up about 290% year-to-date as AI-driven storage demand powers a fierce rally. This repo...
The treasury’s $10B scam warning has sparked a concerted push by industry groups to harden DeFi protocols and staking...
Two budding EV stars, Lucid and Rivian, are racing from zero to scale. This deep dive compares their paths, risks, an...
A Northeast Ohio real estate team built on disciplined systems rises to No. 1 in Ohio among medium teams for 2025, wi...
Icon stock crushed Wednesday as the CRO leader posted a stronger quarter than expected. We break down what drove the ...
Apple reported a strong quarter with better-than-expected growth across iPhone and Services. Analysts say apple’s tar...
As retirement tax planning evolves in 2026, a roth conversion strategy that pairs careful timing with residency moves...
This satellite data stock has pulled back after a scorching rally. In this guide, you’ll learn what powers its busine...
Two former governors unveil a bipartisan coalition designed to prepare America’s workforce for an AI-driven future, w...
The AI hardware boom is fading as demand cools, dragging optical and memory stocks lower and prompting investors to r...